Literature DB >> 15338482

Window of opportunity.

Daniel E Furst.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15338482

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

1.  Association of socioeconomic status with treatment delays, disease activity, joint damage, and disability in rheumatoid arthritis.

Authors:  Emily Molina; Inmaculada Del Rincon; Jose Felix Restrepo; Daniel F Battafarano; Agustin Escalante
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-07       Impact factor: 4.794

2.  [RheumaCheck: development and evaluation of a German language screening instrument for rheumatic diseases].

Authors:  Jutta G Richter; Ewa Wessel; Ralf Klimt; Reinhardt Willers; Matthias Schneider
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

3.  Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial.

Authors:  Tanja Alexandra Stamm; Klaus Peter Machold; Daniel Aletaha; Farideh Alasti; Peter Lipsky; David Pisetsky; Robert Landewe; Desiree van der Heijde; Alexandre Sepriano; Martin Aringer; Dimitri Boumpas; Gerd Burmester; Maurizio Cutolo; Wolfgang Ebner; Winfried Graninger; Tom Huizinga; Georg Schett; Hendrik Schulze-Koops; Paul-Peter Tak; Emilio Martin-Mola; Ferdinand Breedveld; Josef Smolen
Journal:  Arthritis Res Ther       Date:  2018-08-09       Impact factor: 5.156

Review 4.  Window of opportunity in rheumatoid arthritis - definitions and supporting evidence: from old to new perspectives.

Authors:  Leonie E Burgers; Karim Raza; Annette H van der Helm-van Mil
Journal:  RMD Open       Date:  2019-04-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.